LANNETT COMPANY, INC.
Presentation Operator MessageOperator (Operator)Welcome to Lannett Company Fiscal 2022 Second ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Lannett Company, Inc. is engaged in the development, manufacturing, marketing and distribution of generic versions of brand pharmaceutical products. The Company markets approximately 100 products, mainly tablet, capsule or liquid oral generic medications. Its marketed products include generics such as Posaconazole, Fluphenazine, Levothyroxine, Sumatriptan and NDA-based product Numbrino. The Company's product portfolio include Amphetamine IR Tablets, which are used to treat Attention deficit hyperactivity disorder (ADHD) and narcolepsy; Dicyclomine tablets, used for the treatment of functional bowel disorder and irritable bowel syndrome; Levothyroxine Capsules, used to treat patients with hypothyroidism and other conditions, and Numbrino Nasal Solution, used for the induction of local anesthesia of the mucous membranes when performing diagnostic procedures and surgeries on or through the nasal cavities in adults, among others.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +22.35% | 44.12B | |
| +22.22% | 22.61B | |
| +17.63% | 15.11B | |
| +15.73% | 13.61B | |
| +57.91% | 13.34B | |
| -8.98% | 6.94B | |
| -0.05% | 6.79B | |
| +15.65% | 5.75B | |
| -8.87% | 5.73B |
